The much-anticipated Suriya-starrer Kanguva has officially opened advance booking, and fans are already rushing to secure their seats for the epic action drama. Directed by the talented Siruthai Siva, Kanguva promises to be one of the biggest cinematic events of the year, with its release set for November 14, 2024

    SOURCE : ZEE

    Kanguva brings together a star-studded cast, including Suriya, Bobby Deol, and Disha Patani, in a visually stunning saga of good versus evil. The film boasts a budget of over 350 crore, making it one of the most ambitious projects in recent times. Shot across seven countries, the movie showcases breathtaking landscapes and high-stakes action sequences.

    Source:- bbc news

    The story revolves around a warrior from 1678 who is mysteriously linked to a modern-day quest. Suriya will be seen in five different roles, adding depth and complexity to the narrative. The film also features Bobby Deol as the antagonist, along with a talented supporting cast including Yogi Babu, Redin Kingsley, Kovai Sarala, and Anandaraj.

    Kanguva has already garnered significant attention, with advance bookings selling over 50,000 tickets and earning over Rs 8 crore worldwide. The film will be released in multiple formats, including standard, 3D, and IMAX, providing audiences with a variety of viewing exexperience

    The production team, Studio Green, has partnered with top distributors to ensure a worldwide release on a grand scale. With over 10,000 screens confirmed for the release, Kanguva is set to make a massive impact at the box office

    Director Siruthai Siva expressed his excitement about the film’s release, stating, “We’re more than excited. In Tamil Nadu, more than 700 screens have already been confirmed. In South India alone, we’ve locked in over 2,500 screens, and in North India, nearly 3,000 to 3,500 screens. Everything put together, we’re very proud to say, Kanguva will be released on more than 10,000 screens on November 14.”

    Share your views in the comments

     

    Share.

    Leave A Reply